Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis

Published:2019-08 Issue: Volume:134 Page:127-140
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Dafni Urania^ORCID,Tsourti Zoi,Vervita Katerina,Peters Solange

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference57 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: A Cancer Journal for Clinicians,2018

2. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer;Goldstraw;Journal of Thoracic Oncology,2016

3. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade;Iwai;Proceedings of the National Academy of Sciences of the United States of America,2002

4. Enhancement of antitumor immunity by CTLA-4 blockade;Leach;Science (New York),1996

5. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nature Reviews. Cancer,2012

Cited by 149 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety of immune-checkpoint inhibitors plus chemotherapy versus chemotherapy for non-small cell lung cancer: An updated systematic review and meta-analysis;PLOS ONE;2024-02-06

2. Discontinuation risk from adverse events: immunotherapy alone vs. combined with chemotherapy: a systematic review and network meta-analysis;BMC Cancer;2024-01-30

3. Evolving landscape of treatments targeting the microenvironment of liver metastases in non-small cell lung cancer;Chinese Medical Journal;2024-01-22

4. Molecular interactions of antibodies with PD-1/PD-L1 proteins;Immunotherapy;2024-01

5. Histology and molecular testing;Lung Cancer;2024